Pricing
DecImmune Therapeutics
Contact
No bio yet
Christopher K. Mirabelli
President, DecImmune & Managing Director, HealthCare Ventures
This person is not in any teams
This person is not in any offices
DecImmune Therapeutics is a Boston-based biotech company developing drugs for inflammation and autoimmunity.
Industries
Headquarters
Employees
Links
OKX
Brookfield
Vertiv
View more